✦ LIBER ✦

Association Between Overall Incremental Cost And Survival Benefit Of Second Line Chemotherapy/Biologics Treatment Among Elderly Medicare Metastatic Colon Cancer Patients

✍ Scribed by Zheng, Z.; Hanna, N.N.; Onukwugha, E.; Bikov, K.; Seal, B.; Mullins, C.D.

Book ID: 122203216
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 72 KB
Volume: 16
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2013.03.678

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness of Second-Line Chemot

Cost-Effectiveness of Second-Line Chemotherapy/Biologics among Elderly Metastatic Colon Cancer Patients

✍ Zhiyuan Zheng,Eberechukwu Onukwugha,Nader Hanna,Kaloyan Bikov… 📂 Article 📅 2014 🏛 Springer Healthcare Communications 🌐 English ⚖ 825 KB

## Introduction Advancements in chemotherapy treatment have improved the clinical management of metastatic colon cancer (mCC) patients. An increasing number of elderly mCC patients receive various combinations of regimens in second-line chemotherapy/biologics treatment (Tx2) after first-line treatm